论文部分内容阅读
女性生殖器官恶性淋巴瘤是结外淋巴瘤的一部分,可发生于卵巢、宫颈、外阴等部位。病理类型多为B细胞型非霍奇金淋巴瘤,确诊依赖病灶及淋巴结的病理和免疫组化检查。治疗原则以化疗及靶向治疗为主,辅以放疗和手术治疗。环磷酰胺+多柔比星+长春新碱+泼尼松(CHOP)为首选化疗方案,手术以获取足够病理确诊的组织为目的,不主张过大手术范围。以美罗华为代表的靶向药物在淋巴瘤中的疗效已被认可。预后相对良好。
Female genital organs Malignant lymphoma is a part of extranodal lymphoma can occur in the ovary, cervix, vulva and other parts. Most of the pathological types of B-cell non-Hodgkin’s lymphoma, diagnosed on the pathological and immunohistochemical examination of lesions and lymph nodes. The principle of chemotherapy to chemotherapy and targeted therapy, supplemented by radiotherapy and surgical treatment. Cyclophosphamide + doxorubicin + vincristine + prednisone (CHOP) as the preferred chemotherapy regimen for the purpose of obtaining a sufficient number of pathologically confirmed tissues, do not advocate the scope of a large surgery. Targeted drugs represented by rituximab have been approved in lymphomas. The prognosis is relatively good.